Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesRheumatic manifestations of skin disease
Current Opinion in Rheumatology, 10/26/09
Clarke JT et al. – The present review covers new outcome measures, treatments, and unusual manifestations of cutaneous lupus, dermatomyositis, scleroderma, and rheumatoid arthritis. There have been a number of new studies related to validation of disease activity measures, as well as their use in evaluation of new therapies for these conditions. Validated outcome measures are required to perform meaningful studies, and will facilitate organized epidemiologic, quality of life, and therapeutic studies.
Related Articles
Bowel Disease Treatment May Raise Skin Cancer Risk
MedLinePlus, 10/28/09
Relevance Score: 69%
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 69%
Deregulation of cell-death pathways as the cornerstone of skin diseases
Clinical and Experimental Dermatology, 11/03/09
Relevance Score: 67%
Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease
The International Journal of Tuberculosis and Lung Disease, 10/30/09
Relevance Score: 67%
Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year
British Journal of Dermatology, 10/14/09
Relevance Score: 67%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven
Journal of Immunology, 12/15/09
Fetuin-A and interleukin-18 levels in ankylosing spondylitis
International Journal of Rheumatic Diseases, 12/15/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor